(NEW YORK) -- In long-awaited data, Pfizer said its 3-dose vaccine was 80% effective against symptomatic omicron COVID-19 infection among children 6 months to under 5 years old. The company cautioned that estimate was preliminary and could be adjusted as more data is collected. The... Read More.
(NEW YORK) -- The United States is facing a COVID-19 surge this summer as the more contagious delta variant spreads. More than 614,000 Americans have died from COVID-19 and over 4.2 million people have died worldwide, according to real-time data compiled by the Center for... Read More.
(LONDON) -- American biotechnology company Novavax announced Monday that its experimental COVID-19 vaccine was more than 90% effective against symptomatic disease in late-stage clinical trials. Results from the Phase 3 trial, which enrolled nearly 30,000 participants across 119 sites in the United States and Mexico,... Read More.
BY: IVAN PERIERA, ABC NEWS (NEW YORK) — The U.S. Centers for Disease Control and Prevention released new data Monday bolstering previous studies that showed mRNA vaccines are effective at preventing asymptomatic COVID-19 cases. The agency studied 3,950 people who received the Pfizer and... Read More.